Developing a first-in-class drug that pharmacologically activates thermogenesis to treat obesity and metabolic disorders.
Equator Therapeutics is a clinical-stage biotech company developing a novel drug that targets mitochondria to stimulate natural heat production (thermogenesis) as a treatment for obesity and metabolic disorders. The company uses proprietary high-throughput assays to identify selective and safe thermogenic compounds by directly measuring the electrical currents in mitochondria that generate heat. Its long-term pipeline also includes programs targeting other mitochondrial mechanisms. Equator Therapeutics is a product of Equator Therapeutics.